HYPOTHESIS AND THEORY article
Front. Endocrinol.
Sec. Reproduction
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1621558
Prolonged Post-Androgen Abuse Hypogonadism (PPAAH): Potential Mechanisms and a Proposed Standardized Diagnosis
Provisionally accepted
- 1Spaarne Ziekenhuis, Hoofddorp, Netherlands
- 2Android Health Clinic, Utrecht, Netherlands
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Androgen abuse, which is increasingly prevalent, inevitably leads to suppression of the hypothalamic-pituitary-gonadal axis (HPGA). While most individuals recover HPGA function following androgen cessation, a subset experiences prolonged hypogonadism, with symptoms persisting for months or even years. Currently, this condition lacks a standardized definition, complicating both diagnosis and treatment. In this article, we explore the potential mechanisms underlying prolonged hypogonadism after androgen abuse, including the role of prolonged androgen activity, hypothalamic-pituitary alterations, testicular changes, suppression of sex hormone-binding globulin (SHBG), genetic predisposition, and undisclosed ongoing androgen abuse. We propose the term 'Prolonged Post-Androgen Abuse Hypogonadism'(PPAAH) to standardize diagnosis and guide future research. PPAAH is provisionally defined as persistent hypogonadism six months after cessation of androgen abuse, in individuals with a cumulative androgen exposure of at least 150 mg per week for a minimum of six months. Diagnosing PPAAH requires excluding other causes of hypogonadism. This preliminary framework is intended to support further research into the pathophysiology and management of this condition, and may require refinement as further evidence emerges.
Keywords: androgen abuse, Hypogonadism, Anabolic steroid abuse, HPGA recovery, Anabolicandrogenic steroids, Testosterone (androgen), endocrine disruption
Received: 01 May 2025; Accepted: 13 Jun 2025.
Copyright: © 2025 van Os, Smit, Bond and de Ronde. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Joël van Os, Spaarne Ziekenhuis, Hoofddorp, Netherlands
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.